Do analysts prefer AIFU or HIT?

Health In Tech has a consensus target price of $4.00, suggesting a potential upside of 253.98%. Given Health In Tech's stronger consensus rating and higher probable upside, analysts clearly believe Health In Tech is more favorable than AIFU. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AIFU 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Health In Tech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has better earnings and valuation, AIFU or HIT?

Health In Tech has lower revenue, but higher earnings than AIFU. Health In Tech is trading at a lower price-to-earnings ratio than AIFU, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AIFU $556.57M 0.39 -$325.38M $228.00 0.15 Health In Tech $34.08M 2.17 -$1.31M -$0.02 N/A

Is AIFU or HIT more profitable?

Company Net Margins Return on Equity Return on Assets AIFU N/A N/A N/A Health In Tech N/A N/A N/A

Does the media refer more to AIFU or HIT?

In the previous week, Health In Tech had 1 more articles in the media than AIFU. MarketBeat recorded 2 mentions for Health In Tech and 1 mentions for AIFU. AIFU's average media sentiment score of 1.60 beat Health In Tech's score of 1.33 indicating that AIFU is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AIFU 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Health In Tech 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor HIT or SLQT?

In the previous week, Health In Tech had 1 more articles in the media than SelectQuote. MarketBeat recorded 2 mentions for Health In Tech and 1 mentions for SelectQuote. SelectQuote's average media sentiment score of 1.44 beat Health In Tech's score of 1.33 indicating that SelectQuote is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health In Tech 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SelectQuote 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer HIT or RDZN?

Health In Tech presently has a consensus price target of $4.00, suggesting a potential upside of 253.98%. Given Health In Tech's stronger consensus rating and higher probable upside, research analysts plainly believe Health In Tech is more favorable than Roadzen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Health In Tech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Roadzen 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is HIT or RDZN more profitable?

Health In Tech has a net margin of 0.00% compared to Roadzen's net margin of -40.92%. Company Net Margins Return on Equity Return on Assets Health In Tech N/A N/A N/A Roadzen -40.92% N/A -52.35%

Does the media favor HIT or RDZN?

In the previous week, Roadzen had 1 more articles in the media than Health In Tech. MarketBeat recorded 3 mentions for Roadzen and 2 mentions for Health In Tech. Health In Tech's average media sentiment score of 1.33 beat Roadzen's score of 0.74 indicating that Health In Tech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health In Tech 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Roadzen 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend HIT or KG?

Health In Tech currently has a consensus target price of $4.00, suggesting a potential upside of 253.98%. Given Health In Tech's stronger consensus rating and higher probable upside, research analysts plainly believe Health In Tech is more favorable than Ranger Bermuda Topco. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Health In Tech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Ranger Bermuda Topco 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor HIT or KG?

In the previous week, Health In Tech and Health In Tech both had 2 articles in the media. Ranger Bermuda Topco's average media sentiment score of 1.58 beat Health In Tech's score of 1.33 indicating that Ranger Bermuda Topco is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health In Tech 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ranger Bermuda Topco 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Health In Tech (HIT) Competitors

$1.13 +0.06 (+5.61%)

Closing price 04:00 PM Eastern

Extended Trading

$1.13 0.00 (-0.35%)

As of 05:58 PM Eastern

Compare

HIT vs. AIFU, JRVR, SLQT, RDZN, and KG

Should you buy Health In Tech stock or one of its competitors? MarketBeat compares Health In Tech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Health In Tech include AIFU (AIFU), James River Group (JRVR), SelectQuote (SLQT), Roadzen (RDZN), and Ranger Bermuda Topco (KG). These companies are all part of the "insurance" industry.

How does Health In Tech compare to AIFU?

AIFU (NASDAQ:AIFU) and Health In Tech (NASDAQ:HIT) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment.

Health In Tech has lower revenue, but higher earnings than AIFU. Health In Tech is trading at a lower price-to-earnings ratio than AIFU, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AIFU	$556.57M	0.39	-$325.38M	$228.00	0.15
Health In Tech	$34.08M	2.17	-$1.31M	-$0.02	N/A

In the previous week, Health In Tech had 1 more articles in the media than AIFU. MarketBeat recorded 2 mentions for Health In Tech and 1 mentions for AIFU. AIFU's average media sentiment score of 1.60 beat Health In Tech's score of 1.33 indicating that AIFU is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AIFU	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Health In Tech	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

26.7% of AIFU shares are owned by institutional investors. 25.6% of AIFU shares are owned by insiders. Comparatively, 77.7% of Health In Tech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

AIFU has a beta of 0.98, meaning that its stock price is 2% less volatile than the broader market. Comparatively, Health In Tech has a beta of 2.88, meaning that its stock price is 188% more volatile than the broader market.

Health In Tech has a consensus target price of $4.00, suggesting a potential upside of 253.98%. Given Health In Tech's stronger consensus rating and higher probable upside, analysts clearly believe Health In Tech is more favorable than AIFU.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AIFU	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Company	Net Margins	Return on Equity	Return on Assets
AIFU	N/A	N/A	N/A
Health In Tech	N/A	N/A	N/A

Summary

Health In Tech beats AIFU on 8 of the 13 factors compared between the two stocks.

How does Health In Tech compare to James River Group?

James River Group (NASDAQ:JRVR) and Health In Tech (NASDAQ:HIT) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.

James River Group has a net margin of 4.34% compared to Health In Tech's net margin of 0.00%. James River Group's return on equity of 10.79% beat Health In Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
James River Group	4.34%	10.79%	1.13%
Health In Tech	N/A	N/A	N/A

James River Group has a beta of -0.19, meaning that its share price is 119% less volatile than the broader market. Comparatively, Health In Tech has a beta of 2.88, meaning that its share price is 188% more volatile than the broader market.

In the previous week, Health In Tech had 2 more articles in the media than James River Group. MarketBeat recorded 2 mentions for Health In Tech and 0 mentions for James River Group. Health In Tech's average media sentiment score of 1.33 beat James River Group's score of 0.93 indicating that Health In Tech is being referred to more favorably in the news media.

Company	Overall Sentiment
James River Group	Positive
Health In Tech	Positive

James River Group has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than James River Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
James River Group	$687.61M	0.31	$47.43M	$0.34	13.50
Health In Tech	$34.08M	2.17	-$1.31M	-$0.02	N/A

95.2% of James River Group shares are held by institutional investors. 33.8% of James River Group shares are held by insiders. Comparatively, 77.7% of Health In Tech shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

James River Group presently has a consensus target price of $6.44, indicating a potential upside of 40.25%. Health In Tech has a consensus target price of $4.00, indicating a potential upside of 253.98%. Given Health In Tech's stronger consensus rating and higher probable upside, analysts clearly believe Health In Tech is more favorable than James River Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
James River Group	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

James River Group and Health In Tech tied by winning 8 of the 16 factors compared between the two stocks.

How does Health In Tech compare to SelectQuote?

Health In Tech (NASDAQ:HIT) and SelectQuote (NYSE:SLQT) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.

In the previous week, Health In Tech had 1 more articles in the media than SelectQuote. MarketBeat recorded 2 mentions for Health In Tech and 1 mentions for SelectQuote. SelectQuote's average media sentiment score of 1.44 beat Health In Tech's score of 1.33 indicating that SelectQuote is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health In Tech	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SelectQuote	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

SelectQuote has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than SelectQuote, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$34.08M	2.17	-$1.31M	-$0.02	N/A
SelectQuote	$1.53B	0.08	$47.58M	$0.09	7.88

Health In Tech has a beta of 2.88, suggesting that its share price is 188% more volatile than the broader market. Comparatively, SelectQuote has a beta of 1.64, suggesting that its share price is 64% more volatile than the broader market.

34.6% of SelectQuote shares are held by institutional investors. 77.7% of Health In Tech shares are held by insiders. Comparatively, 13.1% of SelectQuote shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

SelectQuote has a net margin of 5.60% compared to Health In Tech's net margin of 0.00%. SelectQuote's return on equity of 20.49% beat Health In Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
SelectQuote	5.60%	20.49%	5.58%

Health In Tech presently has a consensus price target of $4.00, suggesting a potential upside of 253.98%. SelectQuote has a consensus price target of $3.00, suggesting a potential upside of 323.13%. Given SelectQuote's higher probable upside, analysts clearly believe SelectQuote is more favorable than Health In Tech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
SelectQuote	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.25

Summary

SelectQuote beats Health In Tech on 10 of the 15 factors compared between the two stocks.

How does Health In Tech compare to Roadzen?

Health In Tech (NASDAQ:HIT) and Roadzen (NASDAQ:RDZN) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends.

24.7% of Roadzen shares are held by institutional investors. 77.7% of Health In Tech shares are held by insiders. Comparatively, 29.5% of Roadzen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Health In Tech has a beta of 2.88, meaning that its share price is 188% more volatile than the broader market. Comparatively, Roadzen has a beta of 1.19, meaning that its share price is 19% more volatile than the broader market.

Health In Tech has a net margin of 0.00% compared to Roadzen's net margin of -40.92%.

Company	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Roadzen	-40.92%	N/A	-52.35%

In the previous week, Roadzen had 1 more articles in the media than Health In Tech. MarketBeat recorded 3 mentions for Roadzen and 2 mentions for Health In Tech. Health In Tech's average media sentiment score of 1.33 beat Roadzen's score of 0.74 indicating that Health In Tech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health In Tech	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Roadzen	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Health In Tech presently has a consensus price target of $4.00, suggesting a potential upside of 253.98%. Given Health In Tech's stronger consensus rating and higher probable upside, research analysts plainly believe Health In Tech is more favorable than Roadzen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Roadzen	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Health In Tech has higher earnings, but lower revenue than Roadzen. Health In Tech is trading at a lower price-to-earnings ratio than Roadzen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$34.08M	2.17	-$1.31M	-$0.02	N/A
Roadzen	$55.02M	1.78	-$22.52M	-$0.29	N/A

Summary

Health In Tech beats Roadzen on 11 of the 15 factors compared between the two stocks.

How does Health In Tech compare to Ranger Bermuda Topco?

Health In Tech (NASDAQ:HIT) and Ranger Bermuda Topco (NASDAQ:KG) are both small-cap insurance companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

Health In Tech currently has a consensus target price of $4.00, suggesting a potential upside of 253.98%. Given Health In Tech's stronger consensus rating and higher probable upside, research analysts plainly believe Health In Tech is more favorable than Ranger Bermuda Topco.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Ranger Bermuda Topco	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Health In Tech and Health In Tech both had 2 articles in the media. Ranger Bermuda Topco's average media sentiment score of 1.58 beat Health In Tech's score of 1.33 indicating that Ranger Bermuda Topco is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health In Tech	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ranger Bermuda Topco	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Health In Tech has a beta of 2.88, indicating that its stock price is 188% more volatile than the broader market. Comparatively, Ranger Bermuda Topco has a beta of 0.71, indicating that its stock price is 29% less volatile than the broader market.

Ranger Bermuda Topco has lower revenue, but higher earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than Ranger Bermuda Topco, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$34.08M	2.17	-$1.31M	-$0.02	N/A
Ranger Bermuda Topco	$34.05M	2.11	$46.72M	$11.19	0.82

Ranger Bermuda Topco has a net margin of 91.44% compared to Health In Tech's net margin of 0.00%. Health In Tech's return on equity of 0.00% beat Ranger Bermuda Topco's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Ranger Bermuda Topco	91.44%	-27.09%	-3.45%

21.8% of Ranger Bermuda Topco shares are owned by institutional investors. 77.7% of Health In Tech shares are owned by company insiders. Comparatively, 25.9% of Ranger Bermuda Topco shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Health In Tech beats Ranger Bermuda Topco on 9 of the 15 factors compared between the two stocks.

Get Health In Tech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIT vs. The Competition

Export

Metric	Health In Tech	Insurance Agents, Brokers & Service Industry	Finance Sector	NASDAQ Exchange
Market Cap	$74.05M	$1.47B	$14.32B	$12.25B
Dividend Yield	N/A	N/A	5.68%	8.86%
P/E Ratio	-56.50	57.53	20.67	23.92
Price / Sales	2.17	9.73	44.28	113.17
Price / Cash	N/A	69.37	19.44	59.89
Price / Book	N/A	0.58	2.26	6.18
Net Income	-$1.31M	$17.47M	$1.14B	$331.73M
7 Day Performance	6.60%	-0.36%	0.38%	-2.29%
1 Month Performance	6.60%	5.62%	2.12%	-1.62%
1 Year Performance	-5.83%	-2.92%	13.30%	16.79%

Health In Tech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIT Health In Tech	2.8776 of 5 stars	$1.13 +5.6%	$4.00 +254.0%	-2.7%	$74.05M	$34.08M	N/A	79	Positive News Short Interest Decrease
AIFU AIFU	1.8247 of 5 stars	$42.15 flat	N/A	-75.5%	$260.31M	$79.59M	0.14	4,707	Positive News
JRVR James River Group	4.5529 of 5 stars	$4.46 flat	$6.44 +44.3%	-22.0%	$206.22M	$666.71M	13.12	640
SLQT SelectQuote	4.3549 of 5 stars	$0.80 +1.3%	$3.00 +274.5%	-67.2%	$139.42M	$1.53B	8.90	4,269	Positive News
RDZN Roadzen	1.0307 of 5 stars	$1.34 flat	N/A	+8.7%	$113.31M	$55.02M	N/A	324

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HIT) was last updated on 7/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Health In Tech (HIT) Competitors

HIT vs. AIFU, JRVR, SLQT, RDZN, and KG

How does Health In Tech compare to AIFU?

Summary

How does Health In Tech compare to James River Group?

Summary

How does Health In Tech compare to SelectQuote?

Summary

How does Health In Tech compare to Roadzen?

Summary

How does Health In Tech compare to Ranger Bermuda Topco?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIT vs. The Competition

Health In Tech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Health In Tech (HIT) Competitors

HIT vs. AIFU, JRVR, SLQT, RDZN, and KG

How does Health In Tech compare to AIFU?

Which has better earnings and valuation, AIFU or HIT?

Does the media refer more to AIFU or HIT?

Do institutionals and insiders hold more shares of AIFU or HIT?

Which has more volatility and risk, AIFU or HIT?

Do analysts prefer AIFU or HIT?

Is AIFU or HIT more profitable?

Summary

How does Health In Tech compare to James River Group?

Is JRVR or HIT more profitable?

Which has more volatility & risk, JRVR or HIT?

Does the media refer more to JRVR or HIT?

Which has preferable earnings and valuation, JRVR or HIT?

Do institutionals & insiders believe in JRVR or HIT?

Do analysts rate JRVR or HIT?

Summary

How does Health In Tech compare to SelectQuote?

Does the media favor HIT or SLQT?

Which has stronger earnings and valuation, HIT or SLQT?

Which has more volatility & risk, HIT or SLQT?

Do institutionals & insiders have more ownership in HIT or SLQT?

Is HIT or SLQT more profitable?

Do analysts rate HIT or SLQT?

Summary

How does Health In Tech compare to Roadzen?

Do institutionals & insiders have more ownership in HIT or RDZN?

Which has more risk and volatility, HIT or RDZN?

Is HIT or RDZN more profitable?

Does the media favor HIT or RDZN?

Do analysts prefer HIT or RDZN?

Which has better earnings and valuation, HIT or RDZN?

Summary

How does Health In Tech compare to Ranger Bermuda Topco?

Do analysts recommend HIT or KG?

Does the media favor HIT or KG?

Which has more risk and volatility, HIT or KG?

Which has higher earnings & valuation, HIT or KG?

Is HIT or KG more profitable?

Do insiders & institutionals believe in HIT or KG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIT vs. The Competition

Health In Tech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools